Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Rhythm Pharmaceuticals Sector: Biopharmaceuticals, with a focus on rare diseases HQ: 222 Berkeley St, Boston, MA Year Founded: 2008 Key Leaders: David Meeker, MD, Chairman, President, and CEO Number of Employees: 250+ Stage: Public Financial Snapshot: $7.57 billion market cap Notable Investors: Perceptive Advisors, HealthCare Royalty Partners, Ipsen Key Products: Rhythm markets IMCIVREE (setmelanotide) for rare genetic forms of obesity caused by POMC, PCSK1, or LEPR deficiencies
, of Henry Ford Health, Anuj Bhargava, M.D
Since facial fat plays a key role in maintaining youthful contours, its loss can lead to hollowed cheeks, sagging skin, and a more aged appearance
The pons The pons lies in the middle of the brainstem sandwiched in between the medulla oblongata and midbrain and sits just anterior to the cerebellum
And which brands and businesses are making the biggest bets
US$ 26.02
US$ 20.04
US$ 28.38
US$ 22.45
US$ 28.66
US$ 24.22
US$ 27.34
US$ 23.52
